Private: Blog
The Future Costs of Cancer Treatments

Cancer is a complicated disease, with a broad range of types, causes, treatments and outcomes. The medical community is just starting to understand how different each cancer truly can be, which is resonating in the way treatments are developed and delivered to patients. It will be fascinating to see the progress our community makes in cancer treatment development over the coming years.

Looking into the future of cancer treatment, an analysis by the National Institutes of Health estimates that medical expenditures for cancer in the year 2020 are projected to reach at least $158 billion. If newly developed tools for cancer diagnosis, treatment, and follow-up continue to be more expensive, medical expenditures for cancer could reach as high as $207 billion. As a comparison, in 2010, medical costs associated with cancer were projected to reach $124.6 billion, with the highest costs associated with breast cancer ($16.5 billion), followed by colorectal cancer ($14 billion), lymphoma ($12 billion), lung cancer ($12 billion) and prostate cancer ($12 billion).

To read the full analysis, check out this article from the National Institutes of Health.

To help advance the future of cancer treatment, Oncolytics is currently conducting clinical trials of REOLYSIN in six of the ten most common cancers diagnosed in men and five of the ten most diagnosed in women. To learn more about REOLYSIN, check out our video.